From February 5, 2024 to March 31, 2024, the company has repurchased 19,376,561 shares, representing 4.16% for CNY 810.03 million. With this, the company has completed the repurchase of 19,376,561 shares, representing 4.16% for CNY 810.03 million under the buyback announced on February 6, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
43.79 CNY | -2.56% | +7.83% | +16.25% |
05-09 | Andon Health's Subsidiary Gets US FDA's Nod to Market COVID-19, Influenza Test Kit | MT |
05-08 | Andon Health's US Unit Gets FDA Emergency Use Authorization for 3-in-1 Home Test Kits | MT |
1st Jan change | Capi. | |
---|---|---|
+16.25% | 2.8B | |
-1.48% | 8.37B | |
+10.09% | 5.84B | |
+25.61% | 5.4B | |
-4.58% | 4.37B | |
-51.80% | 3.23B | |
+30.25% | 2.26B | |
-8.17% | 2.22B | |
-4.08% | 1.87B | |
+3.02% | 1.6B |
- Stock Market
- Equities
- 002432 Stock
- News Andon Health Co., Ltd.
- Tranche Update on Andon Health Co., Ltd.'s Equity Buyback Plan announced on February 6, 2024.